Articles related to RESEARCH & CLINICAL TRIALS

When hair turns gray, it may signal that the body has also avoided melanoma, as pigment-producing stem cells can either become depleted, which leads to hair graying, or multiply, depending on the kind of stress and signals in their environment.

When glutamate binds to the cancer cells’ NMDA receptors, a channel opens and calcium flows into the cell. This influx triggers molecular signaling cascades that drive tumor growth and metastasis.

The results underscore a clear message: timing and patient selection are key — and early diagnosis and intervention make the biggest difference.

Capvaxive was noninferior to PPSV23 for each of the 12 serotypes present between the 2 vaccines and superior for each of the 9 serotypes unique to Capvaxive.

Castalin can boost the effectiveness of CHK1 inhibitors, a class of drugs currently in phase 1 clinical trials. When tested in cellular models of triple-negative breast cancer, one of the most aggressive forms of the disease, Castalin was shown to enhance the action of these inhibitors.

“With two large phase 3 studies now demonstrating a consistent and significant efficacy profile for AD109, we are closer to delivering the first oral pharmacotherapy for over 80 million US adults with OSA.”